HEADER    TRANSFERASE                             14-JAN-14   4CLI
TITLE     MDANALYSIS FRAME 0: Created by PDBWriter
COMPND    MOL_ID: 1;
COMPND    2 MOLECULE: ALK TYROSINE KINASE RECEPTOR;
COMPND    3 CHAIN: A;
COMPND    4 FRAGMENT: TYROSINE KINASE DOMAIN, RESIDUES 1093-1411;
COMPND    5 SYNONYM: ANAPLASTIC LYMPHOMA KINASE, CD246;
COMPND    6 EC: 2.7.10.1;
COMPND    7 ENGINEERED: YES;
COMPND    8 OTHER_DETAILS: NONPHOSPHORYLATED
REMARK     2
REMARK     2 RESOLUTION.    2.05 ANGSTROMS.
REMARK     3
REMARK     3 REFINEMENT.
REMARK     3   PROGRAM     : CNX 2005
REMARK     3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK     3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK     3               : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK     3               : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK     3               : YIP,DZAKULA)
REMARK     3
REMARK     3  DATA USED IN REFINEMENT.
REMARK     3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05
REMARK     3   RESOLUTION RANGE LOW  (ANGSTROMS) : 52.51
REMARK     3   DATA CUTOFF            (SIGMA(F)) : 0.000
REMARK     3   DATA CUTOFF HIGH         (ABS(F)) : 31364.930
REMARK     3   DATA CUTOFF LOW          (ABS(F)) : 0.0000
REMARK     3   COMPLETENESS (WORKING+TEST)   (%) : 94.8
REMARK     3   NUMBER OF REFLECTIONS             : 35891
REMARK     3
REMARK     3  FIT TO DATA USED IN REFINEMENT.
REMARK     3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK     3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK     3   R VALUE     (WORKING + TEST SET) : 0.199
REMARK     3   R VALUE            (WORKING SET) : 0.198
REMARK     3   FREE R VALUE                     : 0.245
REMARK     3   FREE R VALUE TEST SET SIZE   (%) : 3.100
REMARK     3   FREE R VALUE TEST SET COUNT      : 1103
REMARK     3   ESTIMATED ERROR OF FREE R VALUE  : 0.007
REMARK     3
REMARK     3  FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK     3   R VALUE     (WORKING + TEST SET, NO CUTOFF) : 0.2000
REMARK     3   R VALUE            (WORKING SET, NO CUTOFF) : 0.1990
REMARK     3   FREE R VALUE                    (NO CUTOFF) : 0.245
REMARK     3   FREE R VALUE TEST SET SIZE   (%, NO CUTOFF) : 3.000
REMARK     3   FREE R VALUE TEST SET COUNT     (NO CUTOFF) : 1140
REMARK     3   ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0070
REMARK     3   TOTAL NUMBER OF REFLECTIONS     (NO CUTOFF) : 37677
REMARK     3
REMARK     3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK     3   TOTAL NUMBER OF BINS USED           : 6
REMARK     3   BIN RESOLUTION RANGE HIGH       (A) : 2.05
REMARK     3   BIN RESOLUTION RANGE LOW        (A) : 2.18
REMARK     3   BIN COMPLETENESS (WORKING+TEST) (%) : 88.00
REMARK     3   REFLECTIONS IN BIN    (WORKING SET) : 5398
REMARK     3   BIN R VALUE           (WORKING SET) : 0.2620
REMARK     3   BIN FREE R VALUE                    : 0.3170
REMARK     3   BIN FREE R VALUE TEST SET SIZE  (%) : 2.70
REMARK     3   BIN FREE R VALUE TEST SET COUNT     : 151
REMARK     3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.026
REMARK     3
REMARK     3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK     3   PROTEIN ATOMS            : 2314
REMARK     3   NUCLEIC ACID ATOMS       : 0
REMARK     3   HETEROGEN ATOMS          : 30
REMARK     3   SOLVENT ATOMS            : 232
REMARK     3
REMARK     3  B VALUES.
REMARK     3   FROM WILSON PLOT           (A**2) : 16.00
REMARK     3   MEAN B VALUE      (OVERALL, A**2) : 29.20
REMARK     3   OVERALL ANISOTROPIC B VALUE.
REMARK     3    B11 (A**2) : -2.61000
REMARK     3    B22 (A**2) : -4.27000
REMARK     3    B33 (A**2) : 6.87000
REMARK     3    B12 (A**2) : 0.00000
REMARK     3    B13 (A**2) : 0.00000
REMARK     3    B23 (A**2) : 0.00000
REMARK     3
REMARK     3  ESTIMATED COORDINATE ERROR.
REMARK     3   ESD FROM LUZZATI PLOT        (A) : 0.22
REMARK     3   ESD FROM SIGMAA              (A) : 0.23
REMARK     3   LOW RESOLUTION CUTOFF        (A) : 5.00
REMARK     3
REMARK     3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK     3   ESD FROM C-V LUZZATI PLOT    (A) : 0.29
REMARK     3   ESD FROM C-V SIGMAA          (A) : 0.27
REMARK     3
REMARK     3  RMS DEVIATIONS FROM IDEAL VALUES.
REMARK     3   BOND LENGTHS                 (A) : 0.005
REMARK     3   BOND ANGLES            (DEGREES) : 0.800
REMARK     3   DIHEDRAL ANGLES        (DEGREES) : 19.50
REMARK     3   IMPROPER ANGLES        (DEGREES) : 0.660
REMARK     3
REMARK     3  ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK     3
REMARK     3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA
REMARK     3   MAIN-CHAIN BOND              (A**2) : 1.490 ; 1.500
REMARK     3   MAIN-CHAIN ANGLE             (A**2) : 2.410 ; 2.000
REMARK     3   SIDE-CHAIN BOND              (A**2) : 2.360 ; 2.000
REMARK     3   SIDE-CHAIN ANGLE             (A**2) : 3.440 ; 2.500
REMARK     3
REMARK     3  BULK SOLVENT MODELING.
REMARK     3   METHOD USED : FLAT MODEL
REMARK     3   KSOL        : 0.38
REMARK     3   BSOL        : 62.82
REMARK     3
REMARK     3  NCS MODEL : NONE
REMARK     3
REMARK     3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT
REMARK     3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL
REMARK     3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL
REMARK     3
REMARK     3  PARAMETER FILE  1  : PROTEIN_REP.PARAM
REMARK     3  PARAMETER FILE  2  : DNA-RNA_REP.PARAM
REMARK     3  PARAMETER FILE  3  : WATER_REP.PARAM
REMARK     3  PARAMETER FILE  4  : ION.PARAM
REMARK     3  PARAMETER FILE  5  : UNL.PARAM
REMARK     3  PARAMETER FILE  6  : NULL
REMARK     3  TOPOLOGY FILE  1   : PROTEIN.TOP
REMARK     3  TOPOLOGY FILE  2   : DNA-RNA.TOP
REMARK     3  TOPOLOGY FILE  3   : WATER.TOP
REMARK     3  TOPOLOGY FILE  4   : ION.TOP
REMARK     3  TOPOLOGY FILE  5   : UNL.TOP
REMARK     3  TOPOLOGY FILE  6   : NULL
REMARK     3
REMARK     3  OTHER REFINEMENT REMARKS: NULL
REMARK     4
REMARK     4 4CLI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK     100
REMARK     100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JAN-14.
REMARK     100 THE DEPOSITION ID IS D_1290059394.
REMARK     200
REMARK     200 EXPERIMENTAL DETAILS
REMARK     200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK     200  DATE OF DATA COLLECTION        : 03-FEB-12
REMARK     200  TEMPERATURE           (KELVIN) : 87
REMARK     200  PH                             : 5.5
REMARK     200  NUMBER OF CRYSTALS USED        : 1
REMARK     200
REMARK     200  SYNCHROTRON              (Y/N) : Y
REMARK     200  RADIATION SOURCE               : DIAMOND
REMARK     200  BEAMLINE                       : I03
REMARK     200  X-RAY GENERATOR MODEL          : NULL
REMARK     200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK     200  WAVELENGTH OR RANGE        (A) : 0.976
REMARK     200  MONOCHROMATOR                  : NULL
REMARK     200  OPTICS                         : NULL
REMARK     200
REMARK     200  DETECTOR TYPE                  : PIXEL
REMARK     200  DETECTOR MANUFACTURER          : DECTRIS PILATUS 6M
REMARK     200  INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK     200  DATA SCALING SOFTWARE          : SCALA
REMARK     200
REMARK     200  NUMBER OF UNIQUE REFLECTIONS   : 23831
REMARK     200  RESOLUTION RANGE HIGH      (A) : 1.940
REMARK     200  RESOLUTION RANGE LOW       (A) : 52.510
REMARK     200  REJECTION CRITERIA  (SIGMA(I)) : 1.000
REMARK     200
REMARK     200 OVERALL.
REMARK     200  COMPLETENESS FOR RANGE     (%) : 99.9
REMARK     200  DATA REDUNDANCY                : 6.500
REMARK     200  R MERGE                    (I) : 0.11000
REMARK     200  R SYM                      (I) : NULL
REMARK     200  <I/SIGMA(I)> FOR THE DATA SET  : 12.6000
REMARK     200
REMARK     200 IN THE HIGHEST RESOLUTION SHELL.
REMARK     200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94
REMARK     200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.99
REMARK     200  COMPLETENESS FOR SHELL     (%) : 99.8
REMARK     200  DATA REDUNDANCY IN SHELL       : 6.40
REMARK     200  R MERGE FOR SHELL          (I) : 0.77000
REMARK     200  R SYM FOR SHELL            (I) : NULL
REMARK     200  <I/SIGMA(I)> FOR SHELL         : 2.800
REMARK     200
REMARK     200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK     200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK     200 SOFTWARE USED: CNX
REMARK     200 STARTING MODEL: PDB ENTRY 2XP2
REMARK     200
REMARK     200 REMARK: NONE
REMARK     280
REMARK     280 CRYSTAL
REMARK     280 SOLVENT CONTENT, VS   (%): 41.00
REMARK     280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10
REMARK     280
REMARK     280 CRYSTALLIZATION CONDITIONS: HANGING DROP VAPOR DIFFUSION AT 13
REMARK     280  DEGREES C. EQUAL VOLUMES OF PURIFIED PROTEIN SOLUTION
REMARK     280  (APPROXIMATELY 13-15 MG/ML)CONTAINING 0.0011M INHIBITOR
REMARK     COMPOUND
REMARK     280  WERE COMBINED WITH A SOLUTION CONTAINING: 0.15M AMMONIUM
REMARK     SULFATE,
REMARK     280  9-10.5% MONOMETHYLETHER PEG5K AND 0.1M MES IN THE PH RANGE
REMARK     5.3-
REMARK     280  6.5, PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 286K
REMARK     290
REMARK     290 CRYSTALLOGRAPHIC SYMMETRY
REMARK     290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK     290
REMARK     290      SYMOP   SYMMETRY
REMARK     290     NNNMMM   OPERATOR
REMARK     290       1555   X,Y,Z
REMARK     290       2555   -X+1/2,-Y,Z+1/2
REMARK     290       3555   -X,Y+1/2,-Z+1/2
REMARK     290       4555   X+1/2,-Y+1/2,-Z
REMARK     290
REMARK     290     WHERE NNN -> OPERATOR NUMBER
REMARK     290           MMM -> TRANSLATION VECTOR
REMARK     290
REMARK     290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK     290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK     290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK     290 RELATED MOLECULES.
REMARK     290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK     290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK     290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK     290   SMTRY1   2 -1.000000  0.000000  0.000000       25.88000
REMARK     290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000
REMARK     290   SMTRY3   2  0.000000  0.000000  1.000000       52.51000
REMARK     290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000
REMARK     290   SMTRY2   3  0.000000  1.000000  0.000000       28.64000
REMARK     290   SMTRY3   3  0.000000  0.000000 -1.000000       52.51000
REMARK     290   SMTRY1   4  1.000000  0.000000  0.000000       25.88000
REMARK     290   SMTRY2   4  0.000000 -1.000000  0.000000       28.64000
REMARK     290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000
REMARK     290
REMARK     290 REMARK: NULL
REMARK     300
REMARK     300 BIOMOLECULE: 1
REMARK     300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK     300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK     300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK     300 BURIED SURFACE AREA.
REMARK     350
REMARK     350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK     350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK     350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK     350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK     350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK     350
REMARK     350 BIOMOLECULE: 1
REMARK     350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK     350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK     350 SOFTWARE USED: PISA
REMARK     350 APPLY THE FOLLOWING TO CHAINS: A
REMARK     350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK     350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK     350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK     465
REMARK     465 MISSING RESIDUES
REMARK     465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK     465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK     465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK     465
REMARK     465   M RES C SSSEQI
REMARK     465     MET A  1085
REMARK     465     ALA A  1086
REMARK     465     HIS A  1087
REMARK     465     HIS A  1088
REMARK     465     HIS A  1089
REMARK     465     HIS A  1090
REMARK     465     HIS A  1091
REMARK     465     HIS A  1092
REMARK     465     SER A  1136
REMARK     465     GLY A  1137
REMARK     465     MET A  1138
REMARK     465     PRO A  1139
REMARK     465     ASN A  1140
REMARK     465     ASP A  1141
REMARK     465     PRO A  1142
REMARK     465     SER A  1143
REMARK     465     ALA A  1280
REMARK     465     SER A  1281
REMARK     465     TYR A  1282
REMARK     465     TYR A  1283
REMARK     465     ARG A  1284
REMARK     465     LYS A  1285
REMARK     465     GLY A  1402
REMARK     465     PRO A  1403
REMARK     465     LEU A  1404
REMARK     465     VAL A  1405
REMARK     465     GLU A  1406
REMARK     465     GLU A  1407
REMARK     465     GLU A  1408
REMARK     465     GLU A  1409
REMARK     465     LYS A  1410
REMARK     465     VAL A  1411
REMARK     470
REMARK     470 MISSING ATOM
REMARK     470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK     470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK     470 I=INSERTION CODE):
REMARK     470   M RES CSSEQI  ATOMS
REMARK     470     TYR A1401    CA   C    O    CB   CG   CD1  CD2
REMARK     470     TYR A1401    CE1  CE2  CZ   OH
REMARK     500
REMARK     500 GEOMETRY AND STEREOCHEMISTRY
REMARK     500 SUBTOPIC: TORSION ANGLES
REMARK     500
REMARK     500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK     500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK     500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK     500
REMARK     500 STANDARD TABLE:
REMARK     500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK     500
REMARK     500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK     500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK     500
REMARK     500  M RES CSSEQI        PSI       PHI
REMARK     500    HIS A1124      -71.94   -134.81
REMARK     500    ALA A1126     -177.15    -57.07
REMARK     500    PHE A1127       91.39    -64.28
REMARK     500    GLN A1217       69.62   -110.78
REMARK     500    ARG A1248       -9.07     81.47
REMARK     500    ASP A1249       55.02   -150.64
REMARK     500    SER A1332        1.97     83.72
REMARK     500    GLU A1400       88.84    -45.18
REMARK     500
REMARK     500 REMARK: NULL
REMARK     525
REMARK     525 SOLVENT
REMARK     525
REMARK     525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK     525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK     525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK     525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK     525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK     525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK     525 NUMBER; I=INSERTION CODE):
REMARK     525
REMARK     525  M RES CSSEQI
REMARK     525    HOH A2022        DISTANCE =  5.82 ANGSTROMS
REMARK     800
REMARK     800 SITE
REMARK     800 SITE_IDENTIFIER: AC1
REMARK     800 EVIDENCE_CODE: SOFTWARE
REMARK     800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5P8 A 2401
REMARK     900
REMARK     900 RELATED ENTRIES
REMARK     900 RELATED ID: 4CLJ   RELATED DB: PDB
REMARK     900 STRUCTURE OF L1196M MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN
REMARK     900 COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12 -FLUORO-2,10,16-
REMARK     900 TRIMETHYL-15-OXO-10,15,16,17-
REMARK     TETRAHYDRO-2H-8,4-(METHENO)PYRAZOLO(4,
REMARK     900 3-H)(2,5, 11)BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE).
REMARK     900 RELATED ID: 4CMO   RELATED DB: PDB
REMARK     900 STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX
REMARK     WITH
REMARK     900 THE INHIBITOR 2-((1R)-1-((3-AMINO-6-(
REMARK     2-METHOXYPYRIDIN-3-YL)PYRAZIN-
REMARK     900 2-YL)OXY)ETHYL)-4- FLUORO-N-METHYLBENZAMIDE
REMARK     900 RELATED ID: 4CMT   RELATED DB: PDB
REMARK     900 STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX
REMARK     WITH
REMARK     900 THE INHIBITOR 3-((1R)-1-(5-FLUORO-2-(
REMARK     2H-1,2,3-TRIAZOL-2-YL)PHENYL)
REMARK     900 ETHOXY)-5-(3-( METHYLSULFONYL)PHENYL)PYRIDIN-2-AMINE
REMARK     900 RELATED ID: 4CMU   RELATED DB: PDB
REMARK     900 STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX
REMARK     WITH
REMARK     900 THE INHIBITOR (10R)-7-AMINO-12-FLUORO-1
REMARK     ,3,10,16-TETRAMETHYL-16,17-
REMARK     900 DIHYDRO-1H-8,4-( METHENO)PYRAZOLO(4,3-H)(2,5,11)
REMARK     900 BENZOXADIAZACYCLOTETRADECIN-15(10H)-ONE
REMARK     999
REMARK     999 SEQUENCE
REMARK     999 RESIDUES 1093-1411 OF HUMAN ANAPLASTIC LYMPHOMA KINASE
REMARK     999 PLUS AN ENGINEERED N-TERMINAL HIS-TAG.
CRYST1   51.760   57.280  105.020  90.00  90.00  90.00 P 1           1
HETATM    1  C23 5P8 A2401      26.389  48.223   7.439  1.00 23.46      A    C  
HETATM    2  C12 5P8 A2401      34.400  46.812   8.788  1.00 18.51      A    C  
HETATM    3  C13 5P8 A2401      34.869  46.627  10.104  1.00 19.44      A    C  
HETATM    4  C6  5P8 A2401      29.912  45.453   8.520  1.00 21.70      A    C  
HETATM    5  C15 5P8 A2401      33.647  44.501  10.261  1.00 19.90      A    C  
HETATM    6  C4  5P8 A2401      27.822  45.968   9.493  1.00 24.33      A    C  
HETATM    7  C19 5P8 A2401      27.808  48.406   7.325  1.00 23.70      A    C  
HETATM    8  C5  5P8 A2401      28.848  46.368   8.605  1.00 22.86      A    C  
HETATM    9  C18 5P8 A2401      28.892  47.636   7.807  1.00 24.66      A    C  
HETATM   10  C11 5P8 A2401      33.538  45.835   8.185  1.00 21.83      A    C  
HETATM   11  C10 5P8 A2401      33.140  44.640   8.922  1.00 20.60      A    C  
HETATM   12  C1  5P8 A2401      29.993  44.234   9.242  1.00 20.96      A    C  
HETATM   13  C14 5P8 A2401      34.492  45.482  10.823  1.00 18.25      A    C  
HETATM   14  C22 5P8 A2401      30.060  48.389   7.335  1.00 24.54      A    C  
HETATM   15  C2  5P8 A2401      28.916  43.933  10.099  1.00 21.62      A    C  
HETATM   16  C27 5P8 A2401      33.094  46.124   6.782  1.00 21.88      A    C  
HETATM   17  C28 5P8 A2401      31.552  48.151   7.482  1.00 23.28      A    C  
HETATM   18  C8  5P8 A2401      32.209  43.539   8.352  1.00 20.36      A    C  
HETATM   19  C9  5P8 A2401      32.918  42.172   8.267  1.00 16.74      A    C  
HETATM   20  C25 5P8 A2401      27.689  50.569   5.986  1.00 24.67      A    C  
HETATM   21  C29 5P8 A2401      31.832  47.371   5.063  1.00 24.20      A    C  
HETATM   22  N24 5P8 A2401      25.241  48.074   7.487  1.00 24.04      A    N  
HETATM   23  N3  5P8 A2401      27.839  44.789  10.223  1.00 23.14      A    N  
HETATM   24  N21 5P8 A2401      29.709  49.481   6.657  1.00 26.02      A    N  
HETATM   25  N20 5P8 A2401      28.376  49.478   6.660  1.00 26.02      A    N  
HETATM   26  N26 5P8 A2401      32.178  47.195   6.483  1.00 22.58      A    N  
HETATM   27  N17 5P8 A2401      28.934  42.737  10.852  1.00 19.60      A    N  
HETATM   28  O30 5P8 A2401      33.585  45.367   5.934  1.00 25.59      A    O  
HETATM   29  O7  5P8 A2401      31.035  43.325   9.186  1.00 19.26      A    O  
HETATM   30  F16 5P8 A2401      34.942  45.317  12.063  1.00 22.17      A    F  
CONECT    1    7   22
CONECT    2    3   10
CONECT    3    2   13
CONECT    4    8   12
CONECT    5   11   13
CONECT    6    8   23
CONECT    7    1    9   25
CONECT    8    4    6    9
CONECT    9    7    8   14
CONECT   10    2   11   16
CONECT   11    5   10   18
CONECT   12    4   15   29
CONECT   13    3    5   30
CONECT   14    9   17   24
CONECT   15   12   23   27
CONECT   16   10   26   28
CONECT   17   14   26
CONECT   18   11   19   29
CONECT   19   18
CONECT   20   25
CONECT   21   26
CONECT   22    1
CONECT   23    6   15
CONECT   24   14   25
CONECT   25    7   20   24
CONECT   26   16   17   21
CONECT   27   15
CONECT   28   16
CONECT   29   12   18
CONECT   30   13
END
